National Center for Infectious Diseases   Report issue

Government Phase 2 Phase 3
Founded: Singapore (2019)

Organization Overview

First Clinical Trial
2019
NCT00213031
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

National Center for Infectious Diseases | National Centre for Infectious Diseases

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 3)

Gonorrhea (Phase 2)

Herpes Simplex (Phase 2)

HIV Infections (Phase 1)

Severe Acute Respiratory Syndrome (Phase 3)

Syphilis (Phase 2)

Trichomonas Vaginitis (Phase 2)

Vaginitis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 5